This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Mar 19;360(12):1169-71.

doi: 10.1056/NEJMp0808414.

An uncertain future for cardiovascular drug development?

Alan M Garber¹

Affiliations

PMID: 19297568
DOI: 10.1056/NEJMp0808414

An uncertain future for cardiovascular drug development?

Alan M Garber. N Engl J Med. 2009.

. 2009 Mar 19;360(12):1169-71.

doi: 10.1056/NEJMp0808414.

Author

Alan M Garber¹

Affiliation

¹ Veterans Affairs Palo Alto Health Care System, USA.

PMID: 19297568
DOI: 10.1056/NEJMp0808414

No abstract available

PubMed Disclaimer

Similar articles

Lawsuits anticipated on generic biologicals front.
Fox JL. Fox JL. Nat Biotechnol. 2003 Jul;21(7):721-2. doi: 10.1038/nbt0703-721. Nat Biotechnol. 2003. PMID: 12833078 No abstract available.
Drug Regulation and Pricing--Can Regulators Influence Affordability?
Eichler HG, Hurts H, Broich K, Rasi G. Eichler HG, et al. N Engl J Med. 2016 May 12;374(19):1807-9. doi: 10.1056/NEJMp1601294. N Engl J Med. 2016. PMID: 27168431 No abstract available.
Precompetitive research: a new prescription for drug development?
Woodcock J. Woodcock J. Clin Pharmacol Ther. 2010 May;87(5):521-3. doi: 10.1038/clpt.2010.28. Clin Pharmacol Ther. 2010. PMID: 20407454 No abstract available.
Therapeutic substitution: guilty until proven innocent.
Kereiakes DJ, Willerson JT. Kereiakes DJ, et al. Circulation. 2003 Nov 25;108(21):2611-2. doi: 10.1161/01.CIR.0000103637.50536.CC. Circulation. 2003. PMID: 14638525 Review. No abstract available.
Better medicines for children--where are we now, and where do we want to be?
Rose K. Rose K. Br J Clin Pharmacol. 2005 Jun;59(6):657-9. doi: 10.1111/j.1365-2125.2005.02411.x. Br J Clin Pharmacol. 2005. PMID: 15948927 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Genome-wide association studies of late-onset cardiovascular disease.
Smith JG, Newton-Cheh C. Smith JG, et al. J Mol Cell Cardiol. 2015 Jun;83:131-41. doi: 10.1016/j.yjmcc.2015.04.004. Epub 2015 Apr 11. J Mol Cell Cardiol. 2015. PMID: 25870159 Free PMC article. Review.
A two-year evaluation of the minutes of Investigational New Drug committee meetings.
Raj JP, Gogtay NJ, Thatte UM. Raj JP, et al. Perspect Clin Res. 2021 Oct-Dec;12(4):199-202. doi: 10.4103/picr.PICR_83_19. Epub 2020 May 7. Perspect Clin Res. 2021. PMID: 34760647 Free PMC article.
Advancing cardiovascular research.
Lauer MS. Lauer MS. Chest. 2012 Feb;141(2):500-505. doi: 10.1378/chest.11-2521. Chest. 2012. PMID: 22315116 Free PMC article. Review.
The current state of drug discovery and a potential role for NMR metabolomics.
Powers R. Powers R. J Med Chem. 2014 Jul 24;57(14):5860-70. doi: 10.1021/jm401803b. Epub 2014 Mar 3. J Med Chem. 2014. PMID: 24588729 Free PMC article. Review.
Insights from systems pharmacology into cardiovascular drug discovery and therapy.
Li P, Fu Y, Ru J, Huang C, Du J, Zheng C, Chen X, Li P, Lu A, Yang L, Wang Y. Li P, et al. BMC Syst Biol. 2014 Dec 24;8:141. doi: 10.1186/s12918-014-0141-z. BMC Syst Biol. 2014. PMID: 25539592 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information